# Pathologic Classic HD

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 384110
- Developer: Ice-Pick Lodge
- Publisher: Good Shepherd Entertainment
- Released: 2015 · Genre: Action · List price: $12.99
- Deal grade: A (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $2.0k to $3.0k per month (mid $2.5k)
- Opportunity score: $5.3k/month at x2.10 dormancy multiplier
- Est. lifetime owners: 254.7k · Est. lifetime net revenue: $711.3k
- Review sentiment: 87% positive across 4603 reviews (3919 from Steam purchases)
- Review velocity: 36.0 reviews/month (6-month average)

## Why it's flagged

- Developer silent for 7.4 years
- Studio active elsewhere (6 titles tracked), so this one may welcome a partner
- Last build shipped 10.5 years ago
- Store page localized in only 4 language(s)
- Last discounted 1 months ago, 6 sales in the last 12 months
- Proven demand elasticity: x1.4 review velocity during past deep sales

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $4.6k |
| After VAT / sales tax (-13% blended) | $4.0k |
| After refunds (-9.5% median) | $3.6k |
| Net to developer (after Steam 30%) | $2.5k |

## Monthly review counts, oldest to newest (24 months)

41, 22, 33, 50, 50, 45, 25, 46, 45, 23, 31, 42, 27, 21, 33, 24, 34, 96, 49, 31, 38, 28, 23, 47

## Estimated acquisition range

$60.3k to $120.6k (2-4x the trailing net annuity of $30.2k/year). Same error range applies.

## Analyst notes (AI-assisted)

Pathologic Classic HD is a 2015 remake of Ice-Pick Lodge's cult Russian art-horror RPG about a plague doctor fighting a supernatural plague across a dying town.

This title sits at an unusual intersection: strong residual revenue ($2.5k/mo mid-case), 87% positive reviews, and a franchise with growing mainstream awareness (Pathologic 2 reshaped player expectations). The game is indie-scale quiet rather than dormant, it earns $30k+/year with minimal marketing spend and zero recent discounts. For publishers seeking IP with devoted, creative fan bases (review sample includes player citing it inspired novel-writing), or for studios evaluating back-catalog monetization and remaster candidates, this represents stable long-tail value. Risk: mechanical janky-ness is a feature to some players, a barrier to others; audience remains small and polarized.

- Most realistic play: watch
- Risk (market): Pathologic 2 (2019) is the spiritual successor and now arguably the canonical entry point; Classic HD risks perception as inferior remake rather than vintage artifact.
- Risk (tech): Player consensus acknowledges janky combat, stealth, and UI; a remaster would need to address friction without diluting the game's intentional design language.
- Risk (other): Niche, polarizing art-horror design means ceiling for growth is inherently low; not a title for player-acquisition campaigns.

What players are asking for:
- QoL improvements to UI and map navigation without sacrificing atmosphere or intentional difficulty
- Combat and stealth refinement (especially backstab/hitbox clarity)
- Character interaction replay or New Game+ modes to explore alternate routes

Suggested first moves:
1. Audit Ice-Pick Lodge's roadmap for Classic HD; determine whether a community-facing bugfix or 'definitive edition' patch is feasible or desirable given Pathologic 2 co-existence.
2. Model remaster ROI: mechanically polish combat/stealth/UI while preserving atmosphere and difficulty. Test whether $20–25 remaster would cannibalize the $12.99 current install base or reach players deterred by janky-ness who skipped Pathologic 2.
3. Explore licensing Pathologic IP for transmedia (tabletop, audio drama, graphic novel) to deepen franchise equity without competing with canon games; fan reviews suggest narrative depth that translates beyond gameplay.

Generated 2026-08-20 from public signals and player reviews. Directional, not diligence.

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/384110
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.